| Product Code: ETC9966875 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Genetic Materials Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Genetic Materials Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Genetic Materials Market - Industry Life Cycle |
3.4 United States (US) Genetic Materials Market - Porter's Five Forces |
3.5 United States (US) Genetic Materials Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Genetic Materials Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United States (US) Genetic Materials Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Genetic Materials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for genetic testing and personalized medicine |
4.2.2 Technological advancements in genetic sequencing and analysis techniques |
4.2.3 Growing awareness and acceptance of genetic testing for disease prevention and treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and ethical concerns related to genetic testing |
4.3.2 High costs associated with genetic testing services and products |
4.3.3 Limited reimbursement options for genetic testing by healthcare providers |
5 United States (US) Genetic Materials Market Trends |
6 United States (US) Genetic Materials Market, By Types |
6.1 United States (US) Genetic Materials Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Genetic Materials Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Genetic Materials Market Revenues & Volume, By Dna, 2021- 2031F |
6.1.4 United States (US) Genetic Materials Market Revenues & Volume, By Rna, 2021- 2031F |
6.1.5 United States (US) Genetic Materials Market Revenues & Volume, By Genes, 2021- 2031F |
6.1.6 United States (US) Genetic Materials Market Revenues & Volume, By Chromosomes, 2021- 2031F |
6.2 United States (US) Genetic Materials Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Genetic Materials Market Revenues & Volume, By Proteomics, 2021- 2031F |
6.2.3 United States (US) Genetic Materials Market Revenues & Volume, By Bioinformatics, 2021- 2031F |
6.2.4 United States (US) Genetic Materials Market Revenues & Volume, By Synthetic Biology, 2021- 2031F |
6.2.5 United States (US) Genetic Materials Market Revenues & Volume, By Drug Discovery, 2021- 2031F |
6.2.6 United States (US) Genetic Materials Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Genetic Materials Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Genetic Materials Market Revenues & Volume, By Pharmaceuticals, 2021- 2031F |
6.3.3 United States (US) Genetic Materials Market Revenues & Volume, By Medicines, 2021- 2031F |
6.3.4 United States (US) Genetic Materials Market Revenues & Volume, By Agriculture, 2021- 2031F |
6.3.5 United States (US) Genetic Materials Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Genetic Materials Market Import-Export Trade Statistics |
7.1 United States (US) Genetic Materials Market Export to Major Countries |
7.2 United States (US) Genetic Materials Market Imports from Major Countries |
8 United States (US) Genetic Materials Market Key Performance Indicators |
8.1 Adoption rate of genetic testing by healthcare providers |
8.2 Number of research studies and clinical trials utilizing genetic materials |
8.3 Rate of development and commercialization of new genetic testing technologies |
9 United States (US) Genetic Materials Market - Opportunity Assessment |
9.1 United States (US) Genetic Materials Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Genetic Materials Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United States (US) Genetic Materials Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Genetic Materials Market - Competitive Landscape |
10.1 United States (US) Genetic Materials Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Genetic Materials Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here